Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rhabdomyosarcoma × regorafenib × Clear all

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 12 Carcinoma, Hepatocellular 6 Rectal Neoplasms 2 Liver Neoplasms 2 Glioblastoma 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Meningioma 1 Melanoma 1 MCRC 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Metastases 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Neoplasms 1

Interventions

Temozolomide 8 Vincristine 6 Cyclophosphamide 6 fludarabine 4 Irinotecan 3 pegfilgrastim 2 irinotecan sucrosofate 2 fludarabine phosphate 2 Zoledronic Acid 2 Vinorelbine 2 Filgrastim 2 Dactinomycin 2 talazoparib 1 silmitasertib 1 regorafenib 1 pegylated granulocyte colony-stimulating factor 1 pazopanib 1 liposomal doxorubicin 1 cabozantinib 1 atezolizumab 1 amino-acid, glucose, and electrolyte solution 1 Whole-Body Irradiation 1 Tacrolimus 1 Radiotherapy 1 Mesna 1 Melphalan 1 Influenza Vaccines 1 Indocyanine Green 1 Immunotherapy, Adoptive 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04625907 2024-05-23

FaR-RMS

University of Birmingham

Phase 1/2 Recruiting

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡